Lanraplenib succinate T11824
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.�Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in devel
CAS nr:
1800047-00-0
Purity:
98%
Molecular Weight:
620,64
SMILES:
NC1=CN=CC(C2=CN3C(C(NC4=CC=C(N5CCN(C6COC6)CC5)C=C4)=N2)=NC=C3)=N1.O=C(O)CCC(O)=O.[3/2]
Formula:
C23H25N9O.3/2C4H6O4
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors
Target:
Syk,Syk
